-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Gregory Stuart Smith Purchases 3,500 Shares of ImmunoPrecise Antibodies Ltd (TSE:IPA) Stock
Gregory Stuart Smith Purchases 3,500 Shares of ImmunoPrecise Antibodies Ltd (TSE:IPA) Stock
ImmunoPrecise Antibodies Ltd (TSE:IPA – Get Rating) Director Gregory Stuart Smith purchased 3,500 shares of ImmunoPrecise Antibodies stock in a transaction dated Friday, September 23rd. The stock was bought at an average price of C$5.41 per share, with a total value of C$18,935.00. Following the acquisition, the director now directly owns 42,500 shares of the company's stock, valued at C$229,925.
Gregory Stuart Smith also recently made the following trade(s):
Get ImmunoPrecise Antibodies alerts:- On Monday, August 15th, Gregory Stuart Smith purchased 5,000 shares of ImmunoPrecise Antibodies stock. The stock was bought at an average price of C$6.93 per share, with a total value of C$34,670.00.
ImmunoPrecise Antibodies Price Performance
ImmunoPrecise Antibodies Company Profile
(Get Rating)
IPA is an innovation-driven, technology platform company that supports its pharmaceutical and biotechnology company partners in their quest to discover and develop novel, therapeutic antibodies against all classes of disease targets. The Company aims to transform the conventional, multi-vendor, product development model by bringing innovative and high-throughput, data-driven technologies to its partners, incorporating the advantages of diverse antibody repertoires with the Company's therapeutic antibody discovery suite of technologies, to exploit antibodies of broad epitope coverage, multiple antibody formats, valency and size, and to discover antibodies against multiple/rare epitopes.Featured Articles
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
ImmunoPrecise Antibodies Ltd (TSE:IPA – Get Rating) Director Gregory Stuart Smith purchased 3,500 shares of ImmunoPrecise Antibodies stock in a transaction dated Friday, September 23rd. The stock was bought at an average price of C$5.41 per share, with a total value of C$18,935.00. Following the acquisition, the director now directly owns 42,500 shares of the company's stock, valued at C$229,925.
免疫精製抗體有限公司(東京證券交易所代碼:IPA-GET評級)董事格雷戈裏·斯圖爾特·史密斯在一筆日期為9月23日(星期五)的交易中購買了3,500股免疫精製抗體股票。該股是以每股5.41加元的平均價格購買的,總價值為18,935.00加元。收購完成後,董事現在直接擁有該公司42,500股股票,價值229,925加元。
Gregory Stuart Smith also recently made the following trade(s):
格雷戈裏·斯圖爾特·史密斯最近還進行了以下交易:
- On Monday, August 15th, Gregory Stuart Smith purchased 5,000 shares of ImmunoPrecise Antibodies stock. The stock was bought at an average price of C$6.93 per share, with a total value of C$34,670.00.
- 8月15日,星期一,格雷戈裏·斯圖爾特·史密斯購買了5,000股免疫精抗體股票。該股是以每股6.93加元的平均價格購買的,總價值為34,670.00加元。
ImmunoPrecise Antibodies Price Performance
免疫精確型抗體的性價比
ImmunoPrecise Antibodies Company Profile
免疫精準抗體公司簡介
(Get Rating)
(獲取評級)
Featured Articles
專題文章
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 為什麼特斯拉的股票保持彈性?
- CrowdStrike是否會從增加每股收益指引中獲得提振?
- 好市多盈利後價格疲軟是買入的好時機嗎?
- 需要關注的2只半導體類股走勢逆轉
- 小盤股的裁員是樓市的晴雨表嗎?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
每天收到關於免疫精準抗體的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收最新新聞和分析師對免疫精準抗體和相關公司的評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧